Anna Senczuk

Anna Senczuk

Company: Seqirus Inc.

Job title: Director


Panel Discussion: Reimagining Manufacturing Considerations to Widen the Applications of Next Generation RNA Therapeutics 3:00 pm

What are the differences between first generation and next generation RNA therapeutics manufacturing challenges How can we apply the capacity and speed of manufacturing from the COVID vaccines to next generation RNA therapeutics; is it possible and sustainable? What is the potential and applicability of in vitro synthesis in allowing GMP facilities to switch to…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.